139 related articles for article (PubMed ID: 20200812)
1. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study.
Schütt M; Brinkhoff J; Drenckhan M; Lehnert H; Sommer C
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):449-52. PubMed ID: 20200812
[TBL] [Abstract][Full Text] [Related]
2. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
[TBL] [Abstract][Full Text] [Related]
3. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
[TBL] [Abstract][Full Text] [Related]
4. Effects of topiramate on weight and metabolism in children with epilepsy.
Li HF; Zou Y; Xia ZZ; Gao F; Feng JH; Yang CW
Acta Paediatr; 2009 Sep; 98(9):1521-5. PubMed ID: 19508301
[TBL] [Abstract][Full Text] [Related]
5. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.
Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K
Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570
[TBL] [Abstract][Full Text] [Related]
6. Topiramate induces weight loss and improves insulin sensitivity in dietary obese rats: comparison to sibutramine.
Abo-Elmatty DM; Zaitone SA
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1187-95. PubMed ID: 22165681
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of body weight and serum leptin levels in patients treated with topiramate.
Theisen FM; Beyenburg S; Gebhardt S; Kluge M; Blum WF; Remschmidt H; Elger CE; Hebebrand J
Clin Neuropharmacol; 2008; 31(4):226-30. PubMed ID: 18670246
[TBL] [Abstract][Full Text] [Related]
8. Effects of topiramate use on body composition and resting metabolic rate in migraine patients.
Yaman M; Ucok K; Demirbas H; Genc A; Oruc S; Karabacak H; Koyuncu G
Neurol Sci; 2013 Feb; 34(2):225-9. PubMed ID: 22391675
[TBL] [Abstract][Full Text] [Related]
9. Predictors of weight loss in adults with topiramate-treated epilepsy.
Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
[TBL] [Abstract][Full Text] [Related]
10. Effect of weight loss on high-molecular weight adiponectin in obese children.
Martos-Moreno GÁ; Barrios V; Martínez G; Hawkins F; Argente J
Obesity (Silver Spring); 2010 Dec; 18(12):2288-94. PubMed ID: 20339359
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.
Jürimäe J; Jürimäe T; Ring-Dimitriou S; LeMura LM; Arciero PJ; von Duvillard SP
Metabolism; 2009 May; 58(5):638-43. PubMed ID: 19375586
[TBL] [Abstract][Full Text] [Related]
12. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.
Okuyaz C; Kursel O; Komur M; Tamer L
Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262
[TBL] [Abstract][Full Text] [Related]
14. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
[TBL] [Abstract][Full Text] [Related]
15. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance.
Chang HM; Lee HJ; Park HS; Kang JH; Kim KS; Song YS; Jang YJ
Obesity (Silver Spring); 2010 Nov; 18(11):2105-10. PubMed ID: 20339362
[TBL] [Abstract][Full Text] [Related]
16. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
17. Topiramate weight loss in migraine patients.
Alberici A; Borroni B; Manelli F; Griffini S; Zavarise P; Padovani A; Dalla Volta G
J Neurol Sci; 2009 Mar; 278(1-2):64-5. PubMed ID: 19084843
[TBL] [Abstract][Full Text] [Related]
18. Significance of leptin and high-molecular weight adiponectin in the general population of Japanese male adolescents.
Nakatani H; Hirose H; Yamamoto Y; Saito I; Itoh H
Metabolism; 2008 Feb; 57(2):157-62. PubMed ID: 18191043
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively].
Escobar L; Freire JM; Girón JA; Vázquez JM; Pajares M; Ortego J; Gavilán I; Chover AJ; Carrasco M; Epinosa R; Marín F; Aguilar M
Rev Esp Med Nucl; 2000 Jun; 19(3):199-206. PubMed ID: 11062083
[TBL] [Abstract][Full Text] [Related]
20. Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study.
Verrotti A; Parisi P; Agostinelli S; Loiacono G; Marra F; Coppola G; Pisani LR; Gorgone G; Striano P; Pisani F; Belcastro V
CNS Drugs; 2015 Feb; 29(2):163-9. PubMed ID: 25655110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
